The global gene therapy in CNS disorders market is predicted to generate a market value of US$ 8.2 billion in 2023 and a market value of US$ 113.04 billion by 2033, with a CAGR of 30% from 2023 to 2033. In the historical period 2018 to 2022, the market for gene therapy in CNS illnesses …
Monthly Archives: March 2023
Two Wheeler Aftermarket Components & Consumables Market to expand at a CAGR of 7.8% by 2031
Global sales of Two Wheeler Aftermarket Components & Consumables Market are set to be valued at over US$ 55.33 Billion in 2031, as per Future Market Insights (FMI). The market is poised to expand at over 7.8% CAGR due to the growing sales of two wheelers worldwide. The two-wheeler aftermarket components and consumables market refers to the sales of spare …
Intratumoral Cancer Therapies Market by registering a CAGR of 10% in the forecast period 2023 to 2033
A recently published study by FMI expects the global Intratumoral Cancer Therapies market to garner a market value of US$ 212.96 Billion in 2023 and is expected to accumulate a market value of US$ 552.36 Billion by registering a CAGR of 10% in the forecast period 2023-2033. Growth of the Intratumoral Cancer Therapies market can be attributed to favorable regulatory frameworks for …
Head and Neck Cancer (HNC) Therapeutics Market is expected to surpass an impressive valuation of US$ 5.19 Billion in 2033
The global Head and Neck Cancer (HNC) Therapeutics market is anticipated to surpass a remarkable worth of US$ 1.58 Billion in 2023, with a compound annual growth rate (CAGR) of 12.6% from 2023 to 2033. Developments in the detection and treatment of head and neck cancer (HNC) are expected to propel market expansion as they are less …
Donohue Syndrome Treatment Market reaching a total of US$ 25 Billion in 2033
A recently published study by FMI expects the global Donohue syndrome treatment market to augment at a 4% CAGR from 2023 to 2033. By the end of the said assessment period, a valuation of US$ 25 Billion is expected for the market. The Donohue syndrome treatment market is expected to grow during the forecast period due to …
Continue reading “Donohue Syndrome Treatment Market reaching a total of US$ 25 Billion in 2033”
South Korea Cell and Gene Therapy Manufacturing Market is expected to grow at nearly 34.4% during 2023 to 2033
The global cell and gene therapy manufacturing market is worth US$ 19.3 Billion as of now and expected to reach US$ 240 Billion by the year 2033 at a staggering CAGR of 29% between 2023 and 2033. The changing landscape of treating chronic ailments through advanced therapies is the key factor driving the cell and gene therapy …
Congenital Adrenal Hyperplasia Treatment Market by registering a CAGR of 8.1% in the forecast period 2023 to 2033
During the forecast period 2023 to 2033, the Congenital Adrenal Hyperplasia treatment market is expected to grow at a value of 8.1% CAGR, according to Future Market Insights. By the year 2033, the global market for Congenital Adrenal Hyperplasia treatment is expected to rise up to a market valuation of US$ 892 Million. Growth of the market …
Aircraft Cabin Interior Market Major Revenue Gains are Expected by 2031 | Future Market Insights
According to ESOMAR-certified Future Market Insights’ (FMI), the aircraft cabin interior market is expected to expand at 2.70% CAGR throughout the forecast period. The market is highly competitive with United Technologies Corporation, Safran S.A., Diehl Stiftung & Co. KG, HAECO Group, Honeywell International, Inc., and Panasonic Avionics Corporation encompassing around 50% of global market shares. Aircraft cabin …
Hyperloop Train Market CAGR Projected to Grow at 36.5% through 2033 | Future Market Insights
The global hyperloop train market is anticipated to generate US$ 2.05 Billion in revenue in 2023 and this value is predicted to reach US$ 45 Billion by 2033, by registering a striking CAGR of 36.5% over the forecast period. The Hyperloop train system is designed to operate at speeds of up to 760 miles per …
Peri-implantitis Treatment Market forecast to grow at a CAGR of 8.7% to be valued at US$ 4.5 Billion from 2022 to 2032
The global peri-implantitis treatment market stands at US$ 2.3 Bn as of now and is expected to reach US$ 4.5 Bn by 2032 at a CAGR of 8.7% between 2022 and 2032. NCBI (National Center for Biotechnology Information) says that an average follow-up of 24 months all over the US accounts for 21% of market share at …